Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix

Gynecologic Oncology

Volumn 132, Issue 2, 2014, Pages 474-482

  Wu, Chih Hsien ^a   Ko, Jiunn Liang ^a,b   Chen, Shiuan Chih ^a,b   Lin, Yu Wen ^a   Han, Chih Ping ^a,b   Yang, Ti Yuan ^c   Chien, Ming Hsien ^d,e   Wang, Po Hui ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aldo keto reductase family 1 member C3; Cancer of the uterine cervix; Lipocalin 2; Matrix metalloproteinase 2; Metastasis

Indexed keywords

ALDO-KETO REDUCTASE FAMILY 1 MEMBER C3; CANCER OF THE UTERINE CERVIX; LIPOCALIN 2; MATRIX METALLOPROTEINASE-2; METASTASIS;

3-HYDROXYSTEROID DEHYDROGENASES; ACUTE-PHASE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETON; DISEASE PROGRESSION; FEMALE; GENE SILENCING; HEK293 CELLS; HELA CELLS; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; LIPOCALINS; MATRIX METALLOPROTEINASE 2; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 84894036350     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.11.032     Document Type: Article

References (39)

1. D. Hyndman, D.R. Bauman, V.V. Heredia, and T.M. Penning The aldo-keto reductase superfamily homepage Chem Biol Interact 143-144 2003 621 631
2. T.M. Penning, M.E. Burczynski, J.M. Jez, C.F. Hung, H.K. Lin, and H. Ma et al. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones Biochem J 351 2000 67 77
3. T.M. Penning, and M.C. Byrns Steroid hormone transforming aldo-keto reductases and cancer Ann N Y Acad Sci 1155 2009 33 42
4. T.M. Penning, and J.E. Drury Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms Arch Biochem Biophys 464 2007 241 250
5. N.J. Davies, R.E. Hayden, P.J. Simpson, J. Birtwistle, K. Mayer, and J.P. Ride et al. AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects Cancer Res 69 2009 4769 4775
6. M.C. Byrns, Y. Jin, and T.M. Penning Inhibitors of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights J Steroid Biochem Mol Biol 125 2011 95 104
7. P. Wanichwatanadecha, S. Sirisrimangkorn, J. Kaewprag, and M. Ponglikitmongkol Transactivation activity of human papillomavirus type 16 E6*I on aldo-keto reductase genes enhances chemoresistance in cervical cancer cells J Gen Virol 93 2012 1081 1092
8. T. Matsunaga, A. Hojo, Y. Yamane, S. Endo, O. El-Kabbani, and A. Hara Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers Chem Biol Interact 202 2013 234 242
9. L. Xie, J. Yu, W. Guo, L. Wei, Y. Liu, and X. Wang et al. Aldo-keto reductase 1C3 may be a new radioresistance marker in non-small-cell lung cancer Cancer Gene Ther 20 2013 260 266
10. N. Borregaard, and J.B. Cowland Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein Biometals 19 2006 211 215
11. C. Li, and Y.R. Chan Lipocalin 2 regulation and its complex role in inflammation and cancer Cytokine 56 2011 435 441
12. P.H. Wang, J.L. Ko, S.F. Yang, and L.Y. Lin Implication of human nonmetastatic clone 23 Type 1 and its downstream gene lipocalin 2 in metastasis and patient's survival of cancer of uterine cervix Int J Cancer 129 2011 2380 2389
13. D.S. Straus, G. Pascual, M. Li, J.S. Welch, M. Ricote, and C.H. Hsiang et al. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway Proc Natl Acad Sci U S A 97 2000 4844 4849
14. L.S. Wang, K.C. Chow, Y.C. Wu, T.Y. Lin, and W.Y. Li Inverse expression of dihydrodiol dehydrogenase and glutathione-S-transferase in patients with esophageal squamous cell carcinoma Int J Cancer 111 2004 246 251
15. S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 2009 103 104
16. K.A. Olaussen, A. Dunant, P. Fouret, E. Brambilla, F. Andre, and V. Haddad et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 2006 983 991
17. L.M. McShane, D.G. Altman, W. Sauerbrei, S.E. Taube, M. Gion, and G.M. Clark REporting recommendations for tumour MARKer prognostic studies (REMARK) Br J Cancer 93 2005 387 391
18. M.G. Dozmorov, J.T. Azzarello, J.D. Wren, K.M. Fung, Q. Yang, and J.S. Davis et al. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression BMC Cancer 10 2010 672
19. C.P. Guise, M.R. Abbattista, R.S. Singleton, S.D. Holford, J. Connolly, and G.U. Dachs et al. The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3 Cancer Res 70 2010 1573 1584
20. H.K. Lin, S. Steckelbroeck, K.M. Fung, A.N. Jones, and T.M. Penning Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate Steroids 69 2004 795 801
21. J. Hofland, W.M. van Weerden, N.F. Dits, J. Steenbergen, G.J. van Leenders, and G. Jenster et al. Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer Cancer Res 70 2010 1256 1264
22. R. Lim, N. Ahmed, N. Borregaard, C. Riley, R. Wafai, and E.W. Thompson et al. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition Int J Cancer 120 2007 2426 2434
23. Z. Tong, A.B. Kunnumakkara, H. Wang, Y. Matsuo, P. Diagaradjane, and K.B. Harikumar et al. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer Cancer Res 68 2008 6100 6108
24. S.J. Jones, M.M. Florence, I.R. Ellis, K. Kankova, S.L. Schor, and A.M. Schor Co-expression by keratinocytes of migration stimulating factor (MSF) and a functional inhibitor of its bioactivity (MSFI) Exp Cell Res 313 2007 4145 4157
25. P.K. Mattila, and P. Lappalainen Filopodia: molecular architecture and cellular functions Nat Rev Mol Cell Biol 9 2008 446 454
26. H.J. Lee, E.K. Lee, K.J. Lee, S.W. Hong, Y. Yoon, and J.S. Kim Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells Int J Cancer 118 2006 2490 2497
27. J. Yang, D.R. Bielenberg, S.J. Rodig, R. Doiron, M.C. Clifton, and A.L. Kung et al. Lipocalin 2 promotes breast cancer progression Proc Natl Acad Sci U S A 106 2009 3913 3918
28. I. Martinez, J. Wang, K.F. Hobson, R.L. Ferris, and S.A. Khan Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas Eur J Cancer 43 2007 415 432
29. J. Birtwistle, R.E. Hayden, F.L. Khanim, R.M. Green, C. Pearce, and N.J. Davies et al. The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a) anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis Mutat Res 662 2009 67 74
30. M. Ueda, Y.C. Hung, J.T. Chen, S.H. Chiou, H.H. Huang, and T.Y. Lin et al. Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancer Gynecol Oncol 102 2006 173 181
31. A.K. Jansson, C. Gunnarsson, M. Cohen, T. Sivik, and O. Stal 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer Cancer Res 66 2006 11471 11477
32. T. Suzuki, Y. Miki, T. Moriya, J. Akahira, H. Hirakawa, and N. Ohuchi et al. In situ production of sex steroids in human breast carcinoma Med Mol Morphol 40 2007 121 127
33. H. Cho, and J.H. Kim Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer J Histochem Cytochem 57 2009 513 521
34. G. Delgado, B. Bundy, R. Zaino, B.U. Sevin, W.T. Creasman, and F. Major Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol Oncol 38 1990 352 357
35. A.F. Fuller Jr., N. Elliott, C. Kosloff, W.J. Hoskins, and J.L. Lewis Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix Gynecol Oncol 33 1989 34 39
36. B.U. Sevin, M. Nadji, B. Lampe, Y. Lu, S. Hilsenbeck, and O.R. Koechli et al. Prognostic factors of early stage cervical cancer treated by radical hysterectomy Cancer 76 1995 1978 1986
37. H. Sapp, L. Goetzl, W. Creasman, M. Kohler, P. Underwood, and N. Esnaola Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer Am J Obstet Gynecol 199 2008 196.e1 196.e7
38. G.B. Kristensen, V.M. Abeler, B. Risberg, C. Trop, and M. Bryne Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma Gynecol Oncol 74 1990 245 251
39. D.A. Grisaru, A. Covens, E. Franssen, W. Chapman, P. Shaw, and T. Colgan et al. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma Cancer 97 2003 1904 1908